0001193125-24-140662.txt : 20240516 0001193125-24-140662.hdr.sgml : 20240516 20240516164810 ACCESSION NUMBER: 0001193125-24-140662 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240516 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240516 DATE AS OF CHANGE: 20240516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICAL PROPERTIES TRUST INC CENTRAL INDEX KEY: 0001287865 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32559 FILM NUMBER: 24956356 BUSINESS ADDRESS: STREET 1: 1000 URBAN CENTER DRIVE STREET 2: SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 BUSINESS PHONE: 205-969-3755 MAIL ADDRESS: STREET 1: 1000 URBAN CENTER DRIVE STREET 2: SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MPT Operating Partnership, L.P. CENTRAL INDEX KEY: 0001524607 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-177186 FILM NUMBER: 24956357 BUSINESS ADDRESS: STREET 1: MEDICAL PROPERTIES TRUST, INC. STREET 2: 1000 URBAN CENTER DRIVE, SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 BUSINESS PHONE: 205-969-3755 MAIL ADDRESS: STREET 1: MEDICAL PROPERTIES TRUST, INC. STREET 2: 1000 URBAN CENTER DRIVE, SUITE 501 CITY: BIRMINGHAM STATE: AL ZIP: 35242 8-K 1 d840953d8k.htm 8-K 8-K
MEDICAL PROPERTIES TRUST INCfalse00012878650001524607ALAL 0001287865 2024-05-16 2024-05-16 0001287865 mpw:MptOperatingPartnershipLpMember 2024-05-16 2024-05-16
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
FORM
8-K
 
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 16, 2024
 
 
MEDICAL PROPERTIES TRUST, INC.
MPT OPERATING PARTNERSHIP, L.P.
(Exact Name of Registrant as Specified in Charter)
 
 
Commission File Number
001-32559
Commission File Number
333-177186
 
Maryland
  
20-0191742
Delaware
  
20-0242069
(State or other jurisdiction of
incorporation or organization)
  
(I.R.S. Employer
Identification No.)
1000 Urban Center Drive, Suite 501
Birmingham,
AL
  
35242
(Address of principal executive offices)
  
(Zip Code)
Registrant’s telephone number, including area code (205)
969-3755
 
 
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
 
☐
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
 
☐
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading
Symbol
  
Name of each exchange
on which registered
Common Stock, par value $0.001 per share, of Medical Properties Trust, Inc.   MPW   The New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
Item 3.01.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
As previously reported in the Notification of Late Filing on Form
12b-25
(“Form
12b-25”)
filed by Medical Properties Trust, Inc. and MPT Operating Partnership, L.P. (together, the “Company”) on May 13, 2024, the Company was unable, without unreasonable effort or expense, to file its combined Quarterly Report on Form
10-Q
for the period ended March 31, 2024 (the “Quarterly Report”) by the prescribed due date. The Company was unable to file the Quarterly Report within the prescribed period, as further extended by the filing of the Form
12b-25,
due to the voluntary bankruptcy petition filed by Steward Health Care System LLC, one of the Company’s tenants, four days prior to the due date for the Quarterly Report. As a result of the bankruptcy filing, the Company was required to perform additional procedures to determine and review the measurement and timing of various impairments and its independent registered public accounting firm, PricewaterhouseCoopers LLP (“PWC”), needed additional time to complete its interim review.
On May 16, 2024, the Company received a notice (the “Notice”) from the New York Stock Exchange (“NYSE”) indicating that, due to the delay in filing of the Quarterly Report, the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual, which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the “SEC”).
The Notice has no immediate effect on the listing of the Company’s common stock on the NYSE. Under NYSE rules, the Company has six months from May 15, 2024 to regain compliance with NYSE listing standards by filing the Quarterly Report with the SEC, subject to an additional
six-month
extension at the NYSE’s discretion. The Notice also notes that the NYSE may nevertheless commence delisting procedures at any time during the period that is available to the Company to complete the filing, if it deems that the circumstances warrant.
The Company and PWC continue to dedicate significant resources to complete the necessary work to file the Quarterly Report with the SEC as soon as practicable.
 
Item 7.01.
Regulation FD Disclosure.
As required by Section 802.01E of the NYSE Listed Company Manual, the Company issued a press release on May 16, 2024 announcing that it had received the Notice. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form
8-K.
The information in this Item 7.01, including the information contained in Exhibit 99.1 of this Current Report on Form
8-K,
is furnished herewith and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, regardless of any general incorporation language in such filing.
Safe Harbor Disclosure
This Current Report on
Form 8-K includes
forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements can generally be identified by the use of forward-looking words such as “may”, “will”, “would”, “could”, “expect”, “intend”, “plan”, “estimate”, “target”, “anticipate”, “believe”, “objectives”, “outlook”, “guidance” or other similar words, and include statements regarding our strategies, objectives, future expansion and development activities, asset sales and other liquidity transactions, expected returns on investments and expected financial performance. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results or future events to differ materially from those expressed in or underlying such forward-looking statements, including, but not limited to: (i) the risk that the completion and filing of the Quarterly Report will take longer than expected; (ii) the risk that additional information may arise during the preparation of the Quarterly Report for filing with the SEC; and (iii) the timing of the Company regaining compliance with the NYSE’s continued listing standards. The Company disclaims any responsibility to update such forward-looking statements, which speak only as of the date on which they were made.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits
.
 
Exhibit
Number
   
Description
99.1    Press Release, dated May 16, 2024
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Exchange Act, the registrants have duly caused this report to be signed on their behalf by the undersigned hereunder duly authorized.
 
MEDICAL PROPERTIES TRUST, INC.
By:  
/s/ R. Steven Hamner
Name:   R. Steven Hamner
Title:   Executive Vice President and Chief Financial Officer
 
MPT OPERATING PARTNERSHIP, L.P.
By:  
/s/ R. Steven Hamner
Name:   R. Steven Hamner
Title:   Executive Vice President and Chief Financial Officer of the sole member of the general partner of MPT Operating Partnership, L.P.
Date: May 16, 2024
EX-99.1 2 d840953dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

 

  

Contact: Drew Babin, CFA, CMA

  

Senior Managing Director of Corporate Communications

  

Medical Properties Trust, Inc.

  

(646) 884-9809

  

dbabin@medicalpropertiestrust.com

MEDICAL PROPERTIES TRUST COMMENTS ON DELAYED FORM 10-Q FILING AND RELATED NOTICE FROM NYSE

Birmingham, AL – May 16, 2024 – As described in the Form 12b-25 previously filed by Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) with the Securities and Exchange Commission (the “SEC”), the Company is delayed in the timely filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Quarterly Report”) due to additional review procedures required in light of the voluntary bankruptcy petition filed by Steward Health Care System LLC just days prior to the due date for the Quarterly Report. The Company’s independent registered public accounting firm, PricewaterhouseCoopers LLP (“PWC”) has further advised that it requires additional time to complete its interim review of the Quarterly Report. The Company and PWC continue to dedicate significant resources to complete the necessary work to file the Quarterly Report with the SEC as soon as practicable.

On May 16, 2024, due to the delayed filing of the Quarterly Report, the Company received a notice from the New York Stock Exchange (“NYSE”) that the Company is not in compliance with the NYSE’s timely filing criteria set forth in Section 802.01E of the NYSE Listed Company Manual. The notice has no immediate effect on the listing of the Company’s common stock on the NYSE. Under NYSE rules, the Company has six months from May 15, 2024 to regain compliance with the NYSE listing standards by filing the Quarterly Report with the SEC, subject to an additional six-month extension at the NYSE’s discretion.

About Medical Properties Trust, Inc.

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world’s largest owners of hospital real estate with 436 facilities and approximately 43,000 licensed beds in nine countries and across three continents as of March 31, 2024. MPT’s financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. For more information, please visit the Company’s website at www.medicalpropertiestrust.com.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding the Company’s current expectations with respect to the filing of its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 and related matters, as well as all other statements other than statements of historical fact included in this press release, are forward-looking statements. Forward-looking

 

1

statements can generally be identified by the use of forward-looking words such as “may”, “will”, “would”, “could”, “expect”, “intend”, “plan”, “estimate”, “target”, “anticipate”, “believe” or other similar words. Forward-looking statements involve known and unknown risks and uncertainties, some of which may be beyond our control, that may cause our actual results or future events to differ materially from those expressed in or underlying such forward-looking statements, including, but not limited to: (i) the risk that the completion and filing of the Quarterly Report will take longer than expected; (ii) the risk that additional information that may arise during the preparation of the Quarterly Report for filing with the SEC; and (iii) the timing of the Company regaining compliance with the NYSE’s continued listing standards.

The risks described above are not exhaustive and additional factors could adversely affect our business and financial performance, including the risk factors discussed under the section captioned “Risk Factors” in our most recent Annual Report on Form 10-K, as may be updated in our other filings with the SEC. Readers are cautioned to not place undue reliance on forward-looking statements as predictions of future events. We disclaim any responsibility to update such forward-looking statements, which speak only as of the date on which they were made.

# # #

 

2

EX-101.SCH 3 mpw-20240516.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 4 mpw-20240516_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 5 mpw-20240516_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 6 mpw-20240516_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 7 mpw-20240516_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 8 g840953g0517000508196.jpg GRAPHIC begin 644 g840953g0517000508196.jpg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end XML 10 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover Page
May 16, 2024
Document Information [Line Items]  
Entity Registrant Name MEDICAL PROPERTIES TRUST INC
Amendment Flag false
Entity Central Index Key 0001287865
Document Type 8-K
Document Period End Date May 16, 2024
Entity File Number 001-32559
Entity Incorporation State Country Code MD
Entity Tax Identification Number 20-0191742
Entity Address, Address Line One 1000 Urban Center Drive
Entity Address, Address Line Two Suite 501
Entity Address, City or Town Birmingham
Entity Address, State or Province AL
Entity Address, Postal Zip Code 35242
City Area Code 205
Local Phone Number 969-3755
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.001 per share, of Medical Properties Trust, Inc.
Trading Symbol MPW
Security Exchange Name NYSE
Entity Emerging Growth Company false
MPT Operating Partnership LP [Member]  
Document Information [Line Items]  
Entity Registrant Name MPT OPERATING PARTNERSHIP, L.P.
Entity Central Index Key 0001524607
Entity File Number 333-177186
Entity Incorporation State Country Code DE
Entity Tax Identification Number 20-0242069
Entity Address, Address Line One 1000 Urban Center Drive
Entity Address, Address Line Two Suite 501
Entity Address, City or Town Birmingham
Entity Address, State or Province AL
Entity Address, Postal Zip Code 35242
City Area Code 205
Local Phone Number 969-3755
Entity Emerging Growth Company false
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 2 23 1 false 1 0 false 0 false false R1.htm 1001 - Document - Cover Page Sheet http://www.medicalpropertiestrust.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressStateOrProvince, dei:EntityRegistrantName - d840953d8k.htm 7 d840953d8k.htm mpw-20240516.xsd mpw-20240516_cal.xml mpw-20240516_def.xml mpw-20240516_lab.xml mpw-20240516_pre.xml http://xbrl.sec.gov/dei/2023 true true JSON 18 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d840953d8k.htm": { "nsprefix": "mpw", "nsuri": "http://www.medicalpropertiestrust.com/20240516", "dts": { "inline": { "local": [ "d840953d8k.htm" ] }, "schema": { "local": [ "mpw-20240516.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "mpw-20240516_cal.xml" ] }, "definitionLink": { "local": [ "mpw-20240516_def.xml" ] }, "labelLink": { "local": [ "mpw-20240516_lab.xml" ] }, "presentationLink": { "local": [ "mpw-20240516_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 1, "hidden": { "total": 6, "http://xbrl.sec.gov/dei/2023": 6 }, "contextCount": 2, "entityCount": 1, "segmentCount": 1, "elementCount": 29, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 36 }, "report": { "R1": { "role": "http://www.medicalpropertiestrust.com/role/CoverPage", "longName": "1001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "P05_16_2024To05_16_2024", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d840953d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "P05_16_2024To05_16_2024", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d840953d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "mpw_MptOperatingPartnershipLpMember": { "xbrltype": "domainItemType", "nsuri": "http://www.medicalpropertiestrust.com/20240516", "localname": "MptOperatingPartnershipLpMember", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "MPT Operating Partnership LP [Member]", "documentation": "MPT Operating Partnership LP." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.medicalpropertiestrust.com/role/CoverPage" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 19 0001193125-24-140662-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-140662-xbrl.zip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d840953d8k_htm.xml IDEA: XBRL DOCUMENT 0001287865 2024-05-16 2024-05-16 0001287865 mpw:MptOperatingPartnershipLpMember 2024-05-16 2024-05-16 MEDICAL PROPERTIES TRUST INC false 0001287865 0001524607 AL AL 8-K 2024-05-16 MPT OPERATING PARTNERSHIP, L.P. 001-32559 333-177186 MD 20-0191742 DE 20-0242069 1000 Urban Center Drive 1000 Urban Center Drive Suite 501 Suite 501 Birmingham Birmingham 35242 35242 205 205 969-3755 969-3755 false false false false Common Stock, par value $0.001 per share, of Medical Properties Trust, Inc. MPW NYSE false false